Nomad Foods Limited (NOMD)
(Delayed Data from NYSE)
$17.45 USD
-0.05 (-0.29%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $17.47 +0.02 (0.11%) 6:02 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.45 USD
-0.05 (-0.29%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $17.47 +0.02 (0.11%) 6:02 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
Zacks News
US Foods (USFD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
US Foods (USFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medifast (MED) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 17.99% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Nomad Foods (NOMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate-Palmolive (CL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 1.41% and 2.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Nomad Foods (NOMD) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 23.08% and 6.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kellogg (K) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Kellogg (K) delivered earnings and revenue surprises of 20.88% and 2.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Nomad Foods (NOMD) Q1 Earnings Expected to Decline
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chewy (CHWY) Tumbles 14% on Wider-Than-Expected Q4 Loss
by Zacks Equity Research
Chewy's (CHWY) fourth-quarter fiscal 2021 results reflect supply-chain disruptions and higher inbound freight expenses.
Flowers Foods' (FLO) Prudent Acquisitions & Pricing Aid Sales
by Zacks Equity Research
Flowers Foods (FLO) is focusing on acquisitions to strengthen its product portfolio and expand in untapped markets. The company is benefiting from its pricing efforts for a while now.
Newell's (NWL) NUK Launches Sustainable Baby Collection
by Zacks Equity Research
Newell's (NWL) NUK brand launches its first sustainable babywear products made of recycled fiber. The product line includes seven products available in stores and online at Target.
Are Investors Undervaluing Nomad Foods Limited (NOMD) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nomad Foods (NOMD) Could Find Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Nomad Foods (NOMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Nomad Foods (NOMD) Q4 Earnings Match Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 0% and 1.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Nomad Foods (NOMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Nomad Foods Limited (NOMD) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Clorox (CLX) Lags Q2 Earnings Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of -15.38% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Pick Nomad Foods (NOMD) Stock Now?
by Vedika Agarwal
Is Nomad Foods (NOMD) a great pick from the value investor's perspective right now? Read on to know more.
Nomad Foods (NOMD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 17.14% and 2.75%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Nomad Foods (NOMD) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 18th
by Zacks Equity Research
CYTK, GEVO, ISEE, MCFE, and NOMD have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2021.
Nomad Foods (NOMD) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 26.32% and 3.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Nomad Foods (NOMD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Service Corporation (SCI) Seems to be in a Good Spot: Here's Why
by Zacks Equity Research
Service Corporation (SCI) has been benefiting from greater operations amid the pandemic, which led to increased mortality. Also, solid cost control has been a driver.
Philip Morris (PM) to Boost Smoke-Free Options With Fertin Pharma
by Zacks Equity Research
Philip Morris (PM) is expected to complete the acquisition of Fertin Pharma by fourth-quarter fiscal 2021. The move is likely to help its innovation capabilities in the oral delivery platform.
McCormick's (MKC) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) second-quarter fiscal 2021 results reflect the impact of higher sales driven by growth in the Flavor Solutions unit. Management raises fiscal 2021 view.